TC
ENZY

TFS Capital’s Enzymotec Ltd ENZY Stock Holding History

TFS Capital’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,375
Closed -$94K – 995
2016
Q3 		$94K Sell
13,375
-4,926
-27% -$39.5K 0.02% 655
2016
Q2 		$153K Buy
+18,301
New +$152K 0.03% 794
2014
Q4 		– Sell
-33,089
Closed -$221K – 1276
2014
Q3 		$221K Sell
33,089
-1,655
-5% -$17.9K 0.02% 842
2014
Q2 		$471K Buy
34,744
+11,637
+50% +$195K 0.04% 670
2014
Q1 		$509K Buy
23,107
+13,371
+137% +$354K 0.03% 728
2013
Q4 		$263K Buy
+9,736
New +$232K 0.01% 1155

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return